Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study
Top Cited Papers
Open Access
- 1 January 2015
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 148 (1), 100-107.e1
- https://doi.org/10.1053/j.gastro.2014.09.023
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Projected future increase in aging hepatitis C virus–infected liver transplant candidates: A potential effect of hepatocellular carcinomaLiver Transplantation, 2012
- Viral Hepatitis in Liver TransplantationGastroenterology, 2012
- Hepatitis C therapy before and after liver transplantationLiver Transplantation, 2008
- The natural history of recurrent hepatitis C and what influences thisLiver Transplantation, 2008
- Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapyHepatology, 2005
- Liver Retransplantation: A Single-Center Outcome and Financial AnalysisTransplantation Proceedings, 2005
- Evolution of liver transplantation in Europe: Report of the European Liver Transplant RegistryLiver Transplantation, 2003
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on liver transplantation and hepatitis CLiver Transplantation, 2003
- Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantationJournal of Hepatology, 2003
- A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantationLiver Transplantation, 2002